CCR6 and autoimmune disease: Nonetheless, the novel finding in this study that 1,25(OH)2D3-treated memory CCR6+ Th cells retain their suppressive capacity in synovial fluid suggests that these cells may have therapeutic value in autoimmune diseases such as RA.